Integrative Analysis of Transcriptional Regulatory Network and Copy Number Variation in Intrahepatic Cholangiocarcinoma

Background Transcriptional regulatory network (TRN) is used to study conditional regulatory relationships between transcriptional factors and genes. However few studies have tried to integrate genomic variation information such as copy number variation (CNV) with TRN to find causal disturbances in a network. Intrahepatic cholangiocarcinoma (ICC) is the second most common hepatic carcinoma with high malignancy and poor prognosis. Research about ICC is relatively limited comparing to hepatocellular carcinoma, and there are no approved gene therapeutic targets yet. Method We first constructed TRN of ICC (ICC-TRN) using forward-and-reverse combined engineering method, and then integrated copy number variation information with ICC-TRN to select CNV-related modules and constructed CNV-ICC-TRN. We also integrated CNV-ICC-TRN with KEGG signaling pathways to investigate how CNV genes disturb signaling pathways. At last, unsupervised clustering method was applied to classify samples into distinct classes. Result We obtained CNV-ICC-TRN containing 33 modules which were enriched in ICC-related signaling pathways. Integrated analysis of the regulatory network and signaling pathways illustrated that CNV might interrupt signaling through locating on either genomic sites of nodes or regulators of nodes in a signaling pathway. In the end, expression profiles of nodes in CNV-ICC-TRN were used to cluster the ICC patients into two robust groups with distinct biological function features. Conclusion Our work represents a primary effort to construct TRN in ICC, also a primary effort to try to identify key transcriptional modules based on their involvement of genetic variations shown by gene copy number variations (CNV). This kind of approach may bring the traditional studies of TRN based only on expression data one step further to genetic disturbance. Such kind of approach can easily be extended to other disease samples with appropriate data.

[1]  Tao Huang,et al.  The role of Hepatitis C Virus in the dynamic protein interaction networks of hepatocellular cirrhosis and carcinoma , 2011, Int. J. Comput. Biol. Drug Des..

[2]  Haiyang Xie,et al.  Impacts of TCF7L2 gene polymorphisms on the susceptibility of hepatogenous diabetes and hepatocellular carcinoma in cirrhotic patients. , 2013, Gene.

[3]  P. D. Hodgson,et al.  Effect of Stress on Viral–Bacterial Synergy in Bovine Respiratory Disease: Novel Mechanisms to Regulate Inflammation , 2005, Comparative and functional genomics.

[4]  Shane J. Neph,et al.  Circuitry and Dynamics of Human Transcription Factor Regulatory Networks , 2012, Cell.

[5]  Karthik Devarajan,et al.  Nonnegative Matrix Factorization: An Analytical and Interpretive Tool in Computational Biology , 2008, PLoS Comput. Biol..

[6]  Stefan Wiemann,et al.  KEGGgraph: a graph approach to KEGG PATHWAY in R and bioconductor , 2009, Bioinform..

[7]  J. Mesirov,et al.  GenePattern 2.0 , 2006, Nature Genetics.

[8]  G. Gores,et al.  Clinical diagnosis and staging of cholangiocarcinoma , 2011, Nature Reviews Gastroenterology &Hepatology.

[9]  Ximing J. Yang,et al.  p38delta/MAPK13 as a diagnostic marker for cholangiocarcinoma and its involvement in cell motility and invasion , 2009, International journal of cancer.

[10]  Edwin Wang,et al.  Signaling network assessment of mutations and copy number variations predict breast cancer subtype-specific drug targets. , 2013, Cell reports.

[11]  J. Villard,et al.  Transcription regulation and human diseases. , 2004, Swiss medical weekly.

[12]  Ji-Young Lee,et al.  Chromosomal imbalances in Korean intrahepatic cholangiocarcinoma by comparative genomic hybridization. , 2005, Cancer genetics and cytogenetics.

[13]  Rameen Beroukhim,et al.  Integrative molecular analysis of intrahepatic cholangiocarcinoma reveals 2 classes that have different outcomes. , 2013, Gastroenterology.

[14]  J. Llovet,et al.  Intrahepatic cholangiocarcinoma: pathogenesis and rationale for molecular therapies , 2013, Oncogene.

[15]  Chaochun Wei,et al.  cGRNB: a web server for building combinatorial gene regulatory networks through integrated engineering of seed-matching sequence information and gene expression datasets , 2013, BMC Systems Biology.

[16]  Zhijian Yao,et al.  Estrogen Receptor α Polymorphisms Associated With Susceptibility to Hepatocellular Carcinoma in Hepatitis B Virus Carriers , 2006 .

[17]  M. Wigler,et al.  Circular binary segmentation for the analysis of array-based DNA copy number data. , 2004, Biostatistics.

[18]  D. Green,et al.  Cytoplasmic functions of the tumour suppressor p53 , 2009, Nature.

[19]  B. Black,et al.  Transcription factor pathways and congenital heart disease. , 2012, Current topics in developmental biology.

[20]  Qi Zhou,et al.  Inhibition of Wnt signaling induces cell apoptosis and suppresses cell proliferation in cholangiocarcinoma cells. , 2013, Oncology reports.

[21]  F. Markowetz,et al.  The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups , 2012, Nature.

[22]  A. Rodríguez-Molinero,et al.  Tissue homeostasis and cancer. , 2007, Medical hypotheses.

[23]  Gianluca Bontempi,et al.  minet: A R/Bioconductor Package for Inferring Large Transcriptional Networks Using Mutual Information , 2008, BMC Bioinformatics.

[24]  D. Geynisman,et al.  Toward personalized treatment of advanced biliary tract cancers. , 2012, Discovery medicine.

[25]  A. Kallioniemi,et al.  Rare Copy Number Variants Observed in Hereditary Breast Cancer Cases Disrupt Genes in Estrogen Signaling and TP53 Tumor Suppression Network , 2012, PLoS genetics.

[26]  B. Sander,et al.  Pattern of chromosomal aberrations in primary liver cancers identified by comparative genomic hybridization. , 2009, Human pathology.

[27]  Hui Yu,et al.  Combinatorial network of transcriptional regulation and microRNA regulation in human cancer , 2012, BMC Systems Biology.

[28]  Thomas Werner,et al.  MatInspector and beyond: promoter analysis based on transcription factor binding sites , 2005, Bioinform..

[29]  S. Knudsen,et al.  A new non-linear normalization method for reducing variability in DNA microarray experiments , 2002, Genome Biology.

[30]  Kening Li,et al.  The application of gene co-expression network reconstruction based on CNVs and gene expression microarray data in breast cancer , 2011, Molecular Biology Reports.

[31]  M. Ocker,et al.  Active Wnt signalling is associated with low differentiation and high proliferation in human biliary tract cancer in vitro and in vivo and is sensitive to pharmacological inhibition. , 2009, International journal of oncology.

[32]  K. Leelawat,et al.  Basic fibroblast growth factor induces cholangiocarcinoma cell migration via activation of the MEK1/2 pathway. , 2011, Oncology letters.

[33]  Baofeng Lian,et al.  Comparative analysis of viral protein interaction networks in Hepatitis B virus and Hepatitis C virus infected HCC. , 2014, Biochimica et biophysica acta.

[34]  B. Kholodenko,et al.  Cross-talk between mitogenic Ras/MAPK and survival PI3K/Akt pathways: a fine balance. , 2012, Biochemical Society transactions.

[35]  B. Baum,et al.  RNAi in a postmodern, postgenomic era , 2004, Oncogene.

[36]  Chuan-hai Zhang,et al.  Expression of Smad7 in cholangiocarcinoma: prognostic significance and implications for tumor metastasis. , 2012, Asian Pacific journal of cancer prevention : APJCP.

[37]  B. Kaina,et al.  Rho GTPases: promising cellular targets for novel anticancer drugs. , 2006, Current cancer drug targets.

[38]  Tao Huang,et al.  TF-centered downstream gene set enrichment analysis: Inference of causal regulators by integrating TF-DNA interactions and protein post-translational modifications information , 2010, BMC Bioinformatics.

[39]  J. Demoulin,et al.  A Minimal Connected Network of Transcription Factors Regulated in Human Tumors and Its Application to the Quest for Universal Cancer Biomarkers , 2012, PloS one.

[40]  X. Estivill,et al.  Copy number variants and genetic traits: closer to the resolution of phenotypic to genotypic variability , 2007, Nature Reviews Genetics.

[41]  H. Sakurai.  Targeting of TAK1 in inflammatory disorders and cancer. , 2012, Trends in pharmacological sciences.

[42]  J. Stone.  Regulation and Function of the RasGRP Family of Ras Activators in Blood Cells. , 2011, Genes & cancer.

[43]  W. Breitwieser,et al.  The roles of ATF2 (activating transcription factor 2) in tumorigenesis. , 2012, Biochemical Society transactions.

[44]  Tao Huang,et al.  Differential combinatorial regulatory network analysis related to venous metastasis of hepatocellular carcinoma , 2012, BMC Genomics.

[45]  Yusuke Nakamura,et al.  Inverse correlation of the up‐regulation of FZD10 expression and the activation of β‐catenin in synchronous colorectal tumors , 2009, Cancer science.

[46]  A. Brivanlou,et al.  The BMP Inhibitor Coco Reactivates Breast Cancer Cells at Lung Metastatic Sites , 2012, Cell.

[47]  J. Klein,et al.  Interplay between Akt and p38 MAPK pathways in the regulation of renal tubular cell apoptosis associated with diabetic nephropathy. , 2010, American journal of physiology. Renal physiology.

[48]  F. Liu,et al.  Expression profiling reveals dysregulation of cellular cytoskeletal genes in HBx–induced hepatocarcinogenesis , 2007, Cancer biology & therapy.

[49]  A. Saluja,et al.  Heat shock protein 70 inhibits apoptosis in cancer cells through simultaneous and independent mechanisms. , 2009, Gastroenterology.

[50]  Peter Vajkoczy,et al.  Myeloid Zinc Finger 1 Induces Migration, Invasion, and In vivo Metastasis through Axl Gene Expression in Solid Cancer , 2010, Molecular Cancer Research.

[51]  A. Blais,et al.  Constructing transcriptional regulatory networks. , 2005, Genes & development.

[52]  Karen H. Vousden,et al.  p53 and its mutants in tumor cell migration and invasion , 2011, The Journal of cell biology.

[53]  John T. Wei,et al.  Identification of functionally active, low frequency copy number variants at 15q21.3 and 12q21.31 associated with prostate cancer risk , 2012, Proceedings of the National Academy of Sciences.

[54]  Andrew G. Bunn,et al.  A dendrochronology program library in R (dplR) , 2008 .

[55]  Trey Ideker,et al.  Cytoscape 2.8: new features for data integration and network visualization , 2010, Bioinform..

[56]  Nature Genetics , 1991, Nature.

[57]  Alphonse-E Sirica,et al.  Role of ErbB family receptor tyrosine kinases in intrahepatic cholangiocarcinoma. , 2008, World journal of gastroenterology.